China National Medicines Corporation Ltd.

SHSE:600511 株式レポート

時価総額:CN¥27.3b

China National Medicines マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Guotao Tian

最高経営責任者

CN¥2.6m

報酬総額

CEO給与比率n/a
CEO在任期間2.5yrs
CEOの所有権n/a
経営陣の平均在職期間1.9yrs
取締役会の平均在任期間2.6yrs

経営陣の近況

Recent updates

We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

Nov 12
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease

The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 25
The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Sep 26
China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Sep 10
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO(最高経営責任者

Guotao Tian (53 yo)

2.5yrs

在職期間

CN¥2,550,000

報酬

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Guotao Tian
GM & Director2.5yrsCN¥2.55mデータなし
Fei Chen
Chief Financial Officer1.1yrsCN¥191.30kデータなし
Lichun Luo
Board Secretary2.5yrsCN¥1.15mデータなし
Zhang Ting
Deputy Secretary of the Party Committeeno dataCN¥371.90kデータなし

1.9yrs

平均在職期間

46yo

平均年齢

経験豊富な経営陣: 600511の経営陣は 経験豊富 とはみなされません ( 1.9年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Guotao Tian
GM & Director2.6yrsCN¥2.55mデータなし
Xiuchang Jiang
Chairman13.7yrsデータなしデータなし
Yong Liu
Director12.9yrsデータなしデータなし
Jingyun Liu
Chairman of the Supervisory Board12.9yrsデータなしデータなし
Luwen Shi
Independent Director2.6yrsCN¥200.00kデータなし
Xingxi Yu
Independent Director2.6yrsCN¥200.00kデータなし
Deyong Wen
Director5.5yrsデータなしデータなし
Xin Jiang
Director2.6yrsCN¥2.55mデータなし
Xiaojuan Li
Director2.6yrsデータなしデータなし
Kai Lu
Supervisor2.6yrsデータなしデータなし

2.6yrs

平均在職期間

53yo

平均年齢

経験豊富なボード: 600511の 取締役会経験豊富 ではない ( 2.6年の平均在任期間) ため、新しい取締役会が必要であると考えられます。